Page last updated: 2024-08-26

sr141716 and deoxyglucose

sr141716 has been researched along with deoxyglucose in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Freedland, CS; Porrino, LJ; Smith, HR; Whitlow, CT	1
Alberobello, AT; Beguinot, F; Bifulco, M; D'Esposito, V; Esposito, I; Formisano, P; Gazzerro, P; Laezza, C; Miele, C; Proto, MC	1

Other Studies

2 other study(ies) available for sr141716 and deoxyglucose

Article	Year
Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study. Brain research, 2003, Feb-07, Volume: 962, Issue:1-2 Topics: Animals; Autoradiography; Brain; Carbon Radioisotopes; Conditioning, Operant; Deoxyglucose; Drug Tolerance; Feeding Behavior; Glycolysis; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Reward; Rimonabant; Time Factors	2003
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase. Molecular pharmacology, 2008, Volume: 74, Issue:6 Topics: Animals; Cell Line; Deoxyglucose; Drug Inverse Agonism; Gene Expression Regulation, Enzymologic; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Small Interfering	2008

Article

Year

Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study.

Brain research, 2003, Feb-07, Volume: 962, Issue:1-2

Topics: Animals; Autoradiography; Brain; Carbon Radioisotopes; Conditioning, Operant; Deoxyglucose; Drug Tolerance; Feeding Behavior; Glycolysis; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Reward; Rimonabant; Time Factors

2003

The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase.

Molecular pharmacology, 2008, Volume: 74, Issue:6

Topics: Animals; Cell Line; Deoxyglucose; Drug Inverse Agonism; Gene Expression Regulation, Enzymologic; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Small Interfering

2008